Announcements Trials

Browse Landscape

Phase

Phase 1 4 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Sorafenib 8 Oxaliplatin 7 Bevacizumab 6 sintilimab 5 lenvatinib 5 apatinib 5 Fluorouracil 5 Capecitabine 5 atezolizumab 4 Leucovorin 4 Folfox protocol 4 camrelizumab 3 Drug Therapy 3 tremelimumab 2 durvalumab 2 Thalidomide 2 Radiosurgery 2 Nivolumab 2 Neoadjuvant Therapy 2 Injections 2 Hepatectomy 2 Gemcitabine 2 Ethiodized Oil 2 regorafenib 1 pirarubicin 1 pembrolizumab 1 menatetrenone 1 liposomal doxorubicin 1 lanreotide 1 halofantrine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Carcinoma, Hepatocellular × budigalimab × Clear all

NCT06109272 2025-08-15

LIVIGNO-2

AbbVie

Phase 2/3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡